APO RESEARCH · REPORT
Pharmaceutical Quality Control Release Testing Service
Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical Quality Control Release Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical Quality Control Release Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical Quality Control Release Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Quality Control Release Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Quality Control Release Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical Quality Control Release Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical Quality Control Release Testing Service market include Broughton, SGS, ABL, Almac, VIMTA, Eurofins, Honeyman Group, Kymos and Intertek, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical Quality Control Release Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Quality Control Release Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Quality Control Release Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Quality Control Release Testing Service market.
Pharmaceutical Quality Control Release Testing Service Segment by Company
Broughton
SGS
ABL
Almac
VIMTA
Eurofins
Honeyman Group
Kymos
Intertek
Lucideon
Biovian
CAL-Laboratories
Selvita
RSSL
Pharmaceutical Quality Control Release Testing Service Segment by Type
Dissolution Testing
Anti-Corrosion Testing
ICH Stability Storage and Testing
Others
Pharmaceutical Quality Control Release Testing Service Segment by Application
Medical Raw Materials
Pharmaceutical Intermediates
Drugs and Health Products
Others
Pharmaceutical Quality Control Release Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pharmaceutical Quality Control Release Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical Quality Control Release Testing Service key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical Quality Control Release Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical Quality Control Release Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical Quality Control Release Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical Quality Control Release Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Quality Control Release Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Quality Control Release Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Quality Control Release Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Quality Control Release Testing Service industry.
Chapter 3: Detailed analysis of Pharmaceutical Quality Control Release Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical Quality Control Release Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical Quality Control Release Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Dissolution Testing
- Anti-Corrosion Testing
- ICH Stability Storage and Testing
- Others
Applications
- Medical Raw Materials
- Pharmaceutical Intermediates
- Drugs and Health Products
- Others
Companies covered
- Broughton
- SGS
- ABL
- Almac
- VIMTA
- Eurofins
- Honeyman Group
- Kymos
- Intertek
- Lucideon
- Biovian
- CAL-Laboratories
- Selvita
- RSSL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Quality Control Release Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Quality Control Release Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Quality Control Release Testing Service Market Dynamics
- 2.1 Pharmaceutical Quality Control Release Testing Service Industry Trends
- 2.2 Pharmaceutical Quality Control Release Testing Service Industry Drivers
- 2.3 Pharmaceutical Quality Control Release Testing Service Industry Opportunities and Challenges
- 2.4 Pharmaceutical Quality Control Release Testing Service Industry Restraints
3 Pharmaceutical Quality Control Release Testing Service Market by Company
- 3.1 Global Pharmaceutical Quality Control Release Testing Service Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical Quality Control Release Testing Service Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical Quality Control Release Testing Service Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical Quality Control Release Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical Quality Control Release Testing Service Company Product Type and Application
- 3.6 Global Pharmaceutical Quality Control Release Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical Quality Control Release Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical Quality Control Release Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Quality Control Release Testing Service Market by Type
- 4.1 Pharmaceutical Quality Control Release Testing Service Type Introduction
- 4.1.1 Dissolution Testing
- 4.1.2 Anti-Corrosion Testing
- 4.1.3 ICH Stability Storage and Testing
- 4.1.4 Others
- 4.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Type
- 4.2.1 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical Quality Control Release Testing Service Market by Application
- 5.1 Pharmaceutical Quality Control Release Testing Service Application Introduction
- 5.1.1 Medical Raw Materials
- 5.1.2 Pharmaceutical Intermediates
- 5.1.3 Drugs and Health Products
- 5.1.4 Others
- 5.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Application
- 5.2.1 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical Quality Control Release Testing Service Regional Value Analysis
- 6.1 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Quality Control Release Testing Service Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical Quality Control Release Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Quality Control Release Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical Quality Control Release Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical Quality Control Release Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical Quality Control Release Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical Quality Control Release Testing Service Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical Quality Control Release Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical Quality Control Release Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical Quality Control Release Testing Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Quality Control Release Testing Service Country-level Value Analysis
- 7.1 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical Quality Control Release Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical Quality Control Release Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical Quality Control Release Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical Quality Control Release Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Broughton
- 8.1.1 Broughton Company Information
- 8.1.2 Broughton Business Overview
- 8.1.3 Broughton Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Broughton Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.1.5 Broughton Recent Developments
- 8.2 SGS
- 8.2.1 SGS Company Information
- 8.2.2 SGS Business Overview
- 8.2.3 SGS Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 SGS Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.2.5 SGS Recent Developments
- 8.3 ABL
- 8.3.1 ABL Company Information
- 8.3.2 ABL Business Overview
- 8.3.3 ABL Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 ABL Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.3.5 ABL Recent Developments
- 8.4 Almac
- 8.4.1 Almac Company Information
- 8.4.2 Almac Business Overview
- 8.4.3 Almac Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Almac Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.4.5 Almac Recent Developments
- 8.5 VIMTA
- 8.5.1 VIMTA Company Information
- 8.5.2 VIMTA Business Overview
- 8.5.3 VIMTA Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 VIMTA Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.5.5 VIMTA Recent Developments
- 8.6 Eurofins
- 8.6.1 Eurofins Company Information
- 8.6.2 Eurofins Business Overview
- 8.6.3 Eurofins Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Eurofins Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.6.5 Eurofins Recent Developments
- 8.7 Honeyman Group
- 8.7.1 Honeyman Group Company Information
- 8.7.2 Honeyman Group Business Overview
- 8.7.3 Honeyman Group Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Honeyman Group Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.7.5 Honeyman Group Recent Developments
- 8.8 Kymos
- 8.8.1 Kymos Company Information
- 8.8.2 Kymos Business Overview
- 8.8.3 Kymos Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Kymos Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.8.5 Kymos Recent Developments
- 8.9 Intertek
- 8.9.1 Intertek Company Information
- 8.9.2 Intertek Business Overview
- 8.9.3 Intertek Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Intertek Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.9.5 Intertek Recent Developments
- 8.10 Lucideon
- 8.10.1 Lucideon Company Information
- 8.10.2 Lucideon Business Overview
- 8.10.3 Lucideon Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Lucideon Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.10.5 Lucideon Recent Developments
- 8.11 Biovian
- 8.11.1 Biovian Company Information
- 8.11.2 Biovian Business Overview
- 8.11.3 Biovian Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Biovian Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.11.5 Biovian Recent Developments
- 8.12 CAL-Laboratories
- 8.12.1 CAL-Laboratories Company Information
- 8.12.2 CAL-Laboratories Business Overview
- 8.12.3 CAL-Laboratories Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 CAL-Laboratories Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.12.5 CAL-Laboratories Recent Developments
- 8.13 Selvita
- 8.13.1 Selvita Company Information
- 8.13.2 Selvita Business Overview
- 8.13.3 Selvita Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Selvita Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.13.5 Selvita Recent Developments
- 8.14 RSSL
- 8.14.1 RSSL Company Information
- 8.14.2 RSSL Business Overview
- 8.14.3 RSSL Pharmaceutical Quality Control Release Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 RSSL Pharmaceutical Quality Control Release Testing Service Product Portfolio
- 8.14.5 RSSL Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst